These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 4204091
21. Profile of insulin release due to intrapancreatic glyburide infusion. Colwell AR, Zuckerman L. Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788 [No Abstract] [Full Text] [Related]
23. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A, Mariani MM, Ribes G, Alric R. Acta Diabetol Lat; 1973 Apr; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]
24. Special pharmacology of the new sulfonylurea glimepiride. Geisen K. Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269 [Abstract] [Full Text] [Related]
25. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Parodi FA. Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831 [No Abstract] [Full Text] [Related]
38. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep 27; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related]
39. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Haupt E, Beyer J, Schöffling K. Arzneimittelforschung; 1974 Mar 27; 24(0):418-25. PubMed ID: 4211557 [No Abstract] [Full Text] [Related]